Latest news
AI-Designed Drug Targets an "Undruggable" Cancer Protein - Technology NetworksTechnology Networks · Thu, 06 Aug 2026 08:52:25 GMTFDA Expands Approval of Pluvicto® for Metastatic Prostate Cancer: Targets a Protein Called PSMA - Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center · Thu, 06 Aug 2026 04:00:00 GMT